Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 20, 1985 - Issue 7
Submit an article Journal homepage
20
Views
79
CrossRef citations to date
0
Altmetric
Original Article

Chronic ‘Cryptogenic’ Liver Disease and Malignant Hepatoma in Intermediate AlpharAntitrypsin Deficiency Identified by a Pi Z-Specific Monoclonal Antibody

J. Carlson Dept. of Medicine, Malmö General Hospital, University of Lund, Malmö, Sweden
&
S. Eriksson Dept. of Medicine, Malmö General Hospital, University of Lund, Malmö, Sweden
Pages 835-842 | Received 18 Nov 1984, Accepted 20 Dec 1984, Published online: 08 Jul 2009

Citations (79)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Roberta J. Navickis & Mahlon M. Wilkes. (2004) Update on Research, Diagnosis and Management of Alpha1‐Antitrypsin Deficiency. COPD: Journal of Chronic Obstructive Pulmonary Disease 1:2, pages 279-292.
Read now
S. Lindgren, K. Sjöberg & S. Eriksson. (1994) Unsuspected Coeliac Disease in Chronic ‘Cryptogenic’ Liver Disease. Scandinavian Journal of Gastroenterology 29:7, pages 661-664.
Read now
B. Lindmark & S. Eriksson. (1991) Partial Deficiency of α1-Antichymotrypsin Is Associated with Chronic Cryptogenic Liver Disease. Scandinavian Journal of Gastroenterology 26:5, pages 508-512.
Read now
Ronald D. Feld. (1989) Heterozygosity of α1-Antitrypsin: A Health Risk?. Critical Reviews in Clinical Laboratory Sciences 27:6, pages 461-481.
Read now
R. Olsson, J. Lindberg, O. Weiland & L. Nilsson. (1988) Chronic Active Hepatitis in Sweden the Etiologic Spectrum, Clinical Presentation, and Laboratory Profile. Scandinavian Journal of Gastroenterology 23:4, pages 463-470.
Read now
Pauline Hall, Robert Herrmann, Jim Brennan & Malcolm Mackinnon. (1987) Detection of Alpha-1-Antitrypsin in Hepatocytes in Acute and Chronic Hepatitis. Pathology 19:4, pages 415-418.
Read now
Sten G. Eriksson. (1985) Liver Disease in α1-Antitrypsin Deficiency: Aspects of Incidence and Prognosis. Scandinavian Journal of Gastroenterology 20:8, pages 907-911.
Read now

Articles from other publishers (72)

Alberto Quaglia, Eve A. Roberts & Michael Torbenson. 2024. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver 122 294 .
Francesco Callea, Paola Francalanci & Isabella Giovannoni. (2021) Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases. International Journal of Molecular Sciences 22:11, pages 5778.
Crossref
Gregory Cheeney, Lincoln J. Pac, Purva Gopal, Charles S. Landis, Eric Q. Konnick, Paul E. Swanson, Dina N. Greene, Christina M. Lockwood & Maria Westerhoff. (2019) Increased Frequency of Heterozygous Alpha‐1‐Antitrypsin Deficiency in Liver Explants From Nonalcoholic Steatohepatitis Patients. Liver Transplantation 26:1, pages 17-24.
Crossref
A.P. Lopes, M.A. Mineiro, F. Costa, J. Gomes, C. Santos, C. Antunes, D. Maia, R. Melo, M. Canotilho, E. Magalhães, I. Vicente, C. Valente, B.G. Gonçalves, B. Conde, C. Guimarães, C. Sousa, J. Amado, M.E. Brandão, M. Sucena, M.J. Oliveira, S. Seixas, V. Teixeira & L. Telo. (2018) Portuguese consensus document for the management of alpha-1-antitrypsin deficiency. Pulmonology 24, pages 1-21.
Crossref
Guanyu Hao, Zhi Ping Xu & Li Li. (2018) Manipulating extracellular tumour pH: an effective target for cancer therapy. RSC Advances 8:39, pages 22182-22192.
Crossref
Alberto Quaglia, Eve A. Roberts & Michael Torbenson. 2018. Macsween's Pathology of the Liver. Macsween's Pathology of the Liver 111 274 .
Romil Saxena & Pierre Russo. 2018. Practical Hepatic Pathology: a Diagnostic Approach. Practical Hepatic Pathology: a Diagnostic Approach 133 141 .
Tessa M. Cacciottolo, William T.H. Gelson, Gerald Maguire, Susan E. Davies & William J.H. Griffiths. (2014) Pi*Z heterozygous alpha-1 antitrypsin states accelerate parenchymal but not biliary cirrhosis. European Journal of Gastroenterology & Hepatology 26:4, pages 412-417.
Crossref
A. Lachaux & J. Dumortier. (2014) Atteinte hépatique du déficit héréditaire en alpha-1-antitrypsine. Revue des Maladies Respiratoires 31:4, pages 357-364.
Crossref
Philip Roelandt, Pieter Dobbels, Mina Komuta, Anniek Corveleyn, Marie-Paule Emonds, Tania Roskams, Raymond Aerts, Diethard Monbaliu, Louis Libbrecht, Wim Laleman, Chris Verslype, Werner Van Steenbergen, Schalk van der Merwe, Jacques Pirenne, Frederik Nevens & David Cassiman. (2013) Heterozygous α1-antitrypsin Z allele mutation in presumed healthy donor livers used for transplantation. European Journal of Gastroenterology & Hepatology 25:11, pages 1335-1339.
Crossref
David R. Nelson, Jeffrey Teckman, Adrian M. Di Bisceglie & David A. Brenner. (2012) Diagnosis and Management of Patients With α1-Antitrypsin (A1AT) Deficiency. Clinical Gastroenterology and Hepatology 10:6, pages 575-580.
Crossref
D. Robert Dufour. 2012. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics 1637 1693 .
Richard J. Thompson, Bernard C. Portmann & Eve A. Roberts. 2012. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver 157 259 .
Christiane Sokollik, Abha Gupta & Simon C. Ling. 2012. Primary Liver Cancer. Primary Liver Cancer 143 160 .
Romil Saxena & Pierre Russo. 2011. Practical Hepatic Pathology: A Diagnostic Approach. Practical Hepatic Pathology: A Diagnostic Approach 167 175 .
Manal M. Hassan & Ahmed O. Kaseb. 2011. Hepatocellular Carcinoma:. Hepatocellular Carcinoma: 1 19 .
F.V. Chisari, M. Isogawa & S.F. Wieland.. (2010) Pathogenesis of hepatitis B virus infection. Pathologie Biologie 58:4, pages 258-266.
Crossref
MAY ARROYO & JAMES M. CRAWFORD. 2009. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas 1245 1290 .
Michael Charlton. 2009. Liver Transplantation. Liver Transplantation 169 190 .
Kyrsten D. Fairbanks & Anthony S. Tavill. (2008) Liver Disease in Alpha 1-Antitrypsin Deficiency: A Review. The American Journal of Gastroenterology 103:8, pages 2136-2141.
Crossref
Josephine J Tan, Eva Maria Cutiongco-dela Paz, Jose Maria C Avila & Germana V Gregorio. (2006) Low incidence of alpha 1-antitrypsin deficiency among Filipinos with neonatal cholestatis. Journal of Paediatrics and Child Health 42:11, pages 694-697.
Crossref
Arie Regev, Constanza Guaqueta, Enrique G. Molina, Andrew Conrad, Vishnu Mishra, Mark L. Brantly, Maria Torres, Maria De Medina, Andreas G. Tzakis & Eugene R. Schiff. (2006) Does the Heterozygous State of Alpha-1 Antitrypsin Deficiency Have a Role in Chronic Liver Diseases? Interim Results of a Large Case-Control Study. Journal of Pediatric Gastroenterology & Nutrition 43:1, pages S30-S35.
Crossref
Anurag Maheshwari & Paul J. Thuluvath. (2006) Cryptogenic Cirrhosis and NAFLD: Are They Related?. The American Journal of Gastroenterology 101:3, pages 664-668.
Crossref
Christopher L. Bowlus, Ira Willner, Mark A. Zern, Adrian Reuben, Philip Chen, Brian Holladay, Lianqi Xie, Robert F. Woolson & Charlie Strange. (2005) Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency. Clinical Gastroenterology and Hepatology 3:4, pages 390-396.
Crossref
Sabina Janciauskiene, Sten Eriksson, Francesco Callea, Meera Mallya, Aiwu Zhou, Kuniaki Seyama, Satoru Hata & David A. Lomas. (2004) Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of ?1-antitrypsin. Hepatology 40:5, pages 1203-1210.
Crossref
Zhifu Sun & Ping Yang. (2004) Role of imbalance between neutrophil elastase and α1-antitrypsin in cancer development and progression. The Lancet Oncology 5:3, pages 182-190.
Crossref
Frederick J de Serres. (2003) Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed.. Environmental Health Perspectives 111:16, pages 1851-1854.
Crossref
FJ De Serres, I Blanco & E Fernández-Bustillo. (2003) Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America. Clinical Genetics 64:5, pages 382-397.
Crossref
. (2003) American Thoracic Society/European Respiratory Society Statement. American Journal of Respiratory and Critical Care Medicine 168:7, pages 818-900.
Crossref
FJ De Serres, I Blanco & E Fernández-Bustillo. (2003) Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain. Clinical Genetics 63:6, pages 490-509.
Crossref
Frederick J. de Serres. (2002) Worldwide Racial and Ethnic Distribution of α1-Antitrypsin Deficiency. Chest 122:5, pages 1818-1829.
Crossref
Sabina Janciauskiene, Ruta Dominaitiene, Nils H. Sternby, Eva Piitulainen & Sten Eriksson. (2002) Detection of Circulating and Endothelial Cell Polymers of Z and Wild Type α1-Antitrypsin by a Monoclonal Antibody. Journal of Biological Chemistry 277:29, pages 26540-26546.
Crossref
D Robert Dufour, John A Lott, Frederick S Nolte, David R Gretch, Raymond S Koff & Leonard B Seeff. (2000) Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring. Clinical Chemistry 46:12, pages 2050-2068.
Crossref
Hans-Peter Fischer, M.Elena Ortiz-Pallardó, Yon Ko, Christiane Esch & Hui Zhou. (2000) Chronic liver disease in heterozygous α1-antitrypsin deficiency PiZ. Journal of Hepatology 33:6, pages 883-892.
Crossref
Hui Zhou, M. Elena Ortiz-Pallard�, Yon Ko & Hans-Peter Fischer. (2000) Is heterozygous alpha-1-antitrypsin deficiency type PiZ a risk factor for primary liver carcinoma?. Cancer 88:12, pages 2668-2676.
Crossref
Francis V. Chisari. (2000) Viruses, Immunity, and Cancer: Lessons from Hepatitis B. The American Journal of Pathology 156:4, pages 1117-1132.
Crossref
Buket AltuntaŞ, Aydan Kansu & Nurten Girgin. (2007) Hepatic damage in gluten sensitive enteropathy. Pediatrics International 40:6, pages 597-599.
Crossref
Ivo W. Graziadei, Jacob J. Joseph, Russell H. Wiesner, Terry M. Therneau, Kenneth P. Batts & Michael K. Porayko. (1998) Increased risk of chronic liver failure in adults with heterozygous ?-antitrypsin deficiency. Hepatology 28:4, pages 1058-1063.
Crossref
Yasunari Nakamoto, Luca G. Guidotti, Christian V. Kuhlen, Patricia Fowler & Francis V. Chisari. (1998) Immune Pathogenesis of Hepatocellular Carcinoma. The Journal of Experimental Medicine 188:2, pages 341-350.
Crossref
Hui Zhou & Hans-Peter Fischer. (1998) Liver Carcinoma in PiZ Alpha-1-Antitrypsin Deficiency. The American Journal of Surgical Pathology 22:6, pages 742-748.
Crossref
S. Eriksson & A.-N. Elzouki. (1998) 4 α1-Antitrypsin deficiency. Baillière's Clinical Gastroenterology 12:2, pages 257-273.
Crossref
Hugo R. Rosen. (1998) LIVER DISEASE ASSOCIATED WITH ALPHA1-ANTITRYPSIN DEFICIENCY. Clinics in Liver Disease 2:1, pages 175-185.
Crossref
DONGFENG QU, JEFFREY H TECKMAN & DAVID H PERLMUTTER. (2008) REVIEW: α 1 ‐Antitrypsin deficiency associated liver disease . Journal of Gastroenterology and Hepatology 12:5, pages 404-416.
Crossref
W. Endres. (1997) Inherited metabolic diseases affecting the carrier. Journal of Inherited Metabolic Disease 20:1, pages 9-20.
Crossref
Guido Massi. (1996) Pathogenesis and Pathology of Liver Disease Associated With α1-Antitrypsin Deficiency. Chest 110:6, pages 251S-255S.
Crossref
Giovanni Vennarecci, Bridget K. Gunson, Tariq Ismail, Stefan G. H??bscher, Dierdre A. Kelly, Paul McMaster & Elwyn Elias. (1996) TRANSPLANTATION FOR END STAGE LIVER DISEASE RELATED TO ALPHA 1 ANTITRYPSIN. Transplantation 61:10, pages 1488-1495.
Crossref
F. V. Chisari. 1996. Transgenic Models of Human Viral and Immunological Disease. Transgenic Models of Human Viral and Immunological Disease 149 173 .
Francis V. Chisari. (1995) Hepatitis B virus transgenic mice: Insights into the virus and the disease. Hepatology 22:4, pages 1316-1325.
Crossref
Mårten Segelmark, Abdul-Nasser Elzouki, Jörgen Wieslander & Sten Eriksson. (1995) The PiZ gene of α1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney International 48:3, pages 844-850.
Crossref
Tomas Sveger & Sten Eriksson. (1995) The liver in adolescents with α-antitrypsin deficiency. Hepatology 22:2, pages 514-517.
Crossref
Robert J. Hilsden, Stefan J. Urbanski & Mark G. Swain. (2005) End‐stage liver disease developing with the use of methotrexate in heterozygous α 1 ‐antitrypsin deficiency . Arthritis & Rheumatism 38:7, pages 1014-1018.
Crossref
Jeffrey Teckman & David H. Perlmutter. (1995) Conceptual advances in the pathogenesis and treatment of childhood metabolic liver disease. Gastroenterology 108:4, pages 1263-1279.
Crossref
David H. Perlmutter. (1995) CLINICAL MANIFESTATIONS OF ALPHA1-ANTITRYPSIN DEFICIENCY. Gastroenterology Clinics of North America 24:1, pages 27-43.
Crossref
E. Sevelius, M. Andersson & L. Jönsson. (1994) Hepatic accumulation of alpha-1-antitrypsin in chronic liver disease in the dog. Journal of Comparative Pathology 111:4, pages 401-412.
Crossref
JR Poley. (1994) Malignant liver disease in alpha 1 -antitrypsin deficiency . Acta Paediatrica 83:s393, pages 27-32.
Crossref
W Vogel, T Propst, A Propst, O Dietze, G Judmaier & H Braunsteiner. (1994) Causes of liver disease in an adult population with heterozygous and homozygous alpha 1 -antitrypsin deficiency . Acta Paediatrica 83:s393, pages 24-26.
Crossref
Stephen A. Geller, W. Stephen Nichols, Sungsook Kim, Tanya Tolmachoff, Stephen Lee, Mark J. Dycaico, Katherine Felts & Joseph A. Sorge. (1994) Hepatocarcinogenesis is the sequel to hepatitis in Z#2 α1-antitrypsin transgenic mice: Histopathological and DNA ploidy studies. Hepatology 19:2, pages 389-397.
Crossref
WILLIAM S. ROBINSON. (2008) The role of hepatitis B virus in development of primary hepatocellular carcinoma: Part II. Journal of Gastroenterology and Hepatology 8:1, pages 95-106.
Crossref
Theresa Propst, Albert Propst, Otto Dietze, Gert Judmaier, Herbert Braunsteiner & Wolfgang Vogel. (1992) High Prevalence of Viral Infection in Adults with Homozygous and Heterozygous Alpha 1 -Antitrypsin Deficiency and Chronic Liver Disease . Annals of Internal Medicine 117:8, pages 641-645.
Crossref
Mordechai Rabinovitz, Judith S. Gavaler, Robert H. Kelly, Martin Prieto & David H. Van Thiel. (1992) Lack of increase in heterozygous α1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma. Hepatology 15:3, pages 407-410.
Crossref
Francis V. Chisari. 1992. Molecular Genetic Medicine. Molecular Genetic Medicine 67 104 .
J. M. Zozaya & J. Prieto. 1992. Hepatobiliary Diseases. Hepatobiliary Diseases 859 867 .
F. V. Chisari. 1991. Hepadnaviruses. Hepadnaviruses 85 101 .
D. C. S. Hutchison. (1990) The epidemiology ofα 1-antitrypsin deficiency. Lung 168:S1, pages 535-542.
Crossref
Stephen A. Geller, W. Stephen Nichols, Mark J. Dycaico, Katherine A. Felts & Joseph A. Sorge. (1990) Histopathology of α1-antitrypsin liver disease in a transgenic mouse model. Hepatology 12:1, pages 40-47.
Crossref
J. CARLSON. (2007) Endoplasmic reticulum storage disease. Histopathology 16:3, pages 309-312.
Crossref
A.M. Brind & M.F. Bassendine. (1990) Molecular genetics of chronic liver diseases. Baillière's Clinical Gastroenterology 4:1, pages 233-253.
Crossref
Duncan C.S. Hutchison. (1988) Natural history of alpha-1-protease inhibitor deficiency. The American Journal of Medicine 84, pages 3-12.
Crossref
Duncan C.S. Hutchison. (1988) Natural history of alpha-1-protease inhibitor deficiency. The American Journal of Medicine 84:6, pages 3-12.
Crossref
Joseph J. Crowley, Harvey L. Sharp, Esther Freier, Kamal G. Ishak & Patrick Schow. (1987) Fatal liver disease associated with α1-antitrypsin deficiency PiM1/PiMduarte. Gastroenterology 93:2, pages 242-244.
Crossref
Sten Eriksson, Joyce Carlson & Ramon Velez. (1986) Risk of Cirrhosis and Primary Liver Cancer in Alpha 1 -Antitrypsin Deficiency . New England Journal of Medicine 314:12, pages 736-739.
Crossref
STEN ERIKSSON, BERTIL LINDMARK & SIGVARD OLSSON. (2009) Lack of Association between Hemochromatosis and α‐Antitrypsin Deficiency. Acta Medica Scandinavica 219:3, pages 291-294.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.